Regulation of the T cell response
暂无分享,去创建一个
[1] L. Fouser,et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.
[2] J. Powell. The induction and maintenance of T cell anergy. , 2006, Clinical immunology.
[3] L. Cosmi,et al. Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release. , 2006, The Journal of allergy and clinical immunology.
[4] H. Weiner,et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.
[5] C. Tato,et al. Immunology: What does it mean to be just 17? , 2006, Nature.
[6] Y. Iwakura,et al. The IL-23/IL-17 axis in inflammation. , 2006, The Journal of clinical investigation.
[7] Niamh E Mangan,et al. Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion , 2006, The Journal of experimental medicine.
[8] M. D’Elios,et al. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. , 2006, The Journal of clinical investigation.
[9] R. Pelanda,et al. Receptor editing for better or for worse. , 2006, Current opinion in immunology.
[10] H. Bobby Gaspar,et al. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype , 2006, British journal of haematology.
[11] C. Dong. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells , 2006, Nature Reviews Immunology.
[12] S. Ziegler. FOXP3: of mice and men. , 2006, Annual review of immunology.
[13] Michael Loran Dustin,et al. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo , 2006, The Journal of experimental medicine.
[14] P. Krammer,et al. Death receptor signaling and its function in the immune system. , 2006, Current directions in autoimmunity.
[15] A. Enk. DCs and cytokines cooperate for the induction of tregs. , 2006, Ernst Schering Research Foundation workshop.
[16] S. Sudowe,et al. Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells. , 2006, The Journal of allergy and clinical immunology.
[17] M. Rotondi,et al. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. , 2005, The Journal of allergy and clinical immunology.
[18] J. Bluestone,et al. How do CD4+CD25+ regulatory T cells control autoimmunity? , 2005, Current opinion in immunology.
[19] S. Ziegler,et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. , 2005, The Journal of clinical investigation.
[20] Ying Wang,et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.
[21] S. Mazmanian,et al. An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.
[22] G. Ruthel,et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] T. Mcclanahan,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.
[24] P. De Baetselier,et al. Lipoprotein I, a TLR2/4 Ligand Modulates Th2-Driven Allergic Immune Responses , 2005, The Journal of Immunology.
[25] L. Peltonen,et al. Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views on molecular basis of autoimmunity. , 2005, Journal of autoimmunity.
[26] Maureen A Su,et al. Aire: an update. , 2004, Current opinion in immunology.
[27] M. Kronenberg,et al. Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.
[28] J. Bluestone,et al. Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell function , 2004 .
[29] L. Chess,et al. An integrated view of suppressor T cell subsets in immunoregulation. , 2004, The Journal of clinical investigation.
[30] M. Claesson,et al. CD4+CD25+ regulatory T cells: I. Phenotype and physiology , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[31] A. Lindén,et al. Interleukin-17 family members and inflammation. , 2004, Immunity.
[32] A. Iwasaki,et al. Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.
[33] B. Kyewski,et al. Self-representation in the thymus: an extended view , 2004, Nature Reviews Immunology.
[34] F. Simons,et al. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. , 2004, The Journal of allergy and clinical immunology.
[35] P. Lipsky,et al. Generation and Regulation of Human Th1-Biased Immune Responses In Vivo: A Critical Role for IL-4 and IL-10 1 , 2004, The Journal of Immunology.
[36] B. Stockinger,et al. IL-10-Secreting Regulatory T Cells Do Not Express Foxp3 but Have Comparable Regulatory Function to Naturally Occurring CD4+CD25+ Regulatory T Cells 1 , 2004, The Journal of Immunology.
[37] Richard A Flavell,et al. Instruction of Distinct CD4 T Helper Cell Fates by Different Notch Ligands on Antigen-Presenting Cells , 2004, Cell.
[38] S. Zheng,et al. Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity: The Role of IL-2, TGF-β, and IL-101 , 2004, The Journal of Immunology.
[39] Peter R. Galle,et al. Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7 , 2004, The Journal of Immunology.
[40] D. Klinman. Immunotherapeutic uses of CpG oligodeoxynucleotides , 2004, Nature Reviews Immunology.
[41] R. Flavell,et al. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[42] J. Bluestone,et al. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. , 2004, European journal of immunology.
[43] Li Li,et al. Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.
[44] T. Mcclanahan,et al. Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.
[45] S. Nakae,et al. Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice 1 , 2003, The Journal of Immunology.
[46] S. Szabo,et al. Molecular mechanisms regulating Th1 immune responses. , 2003, Annual review of immunology.
[47] Timothy K Starr,et al. Positive and negative selection of T cells. , 2003, Annual review of immunology.
[48] S. Ziegler,et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. , 2003, The Journal of clinical investigation.
[49] Sergio Romagnani,et al. An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4 , 2003, The Journal of experimental medicine.
[50] T. Moseley,et al. Interleukin-17 family and IL-17 receptors. , 2003, Cytokine & growth factor reviews.
[51] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[52] R. Kastelein,et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.
[53] L. Cosmi,et al. The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells. , 2003, The Journal of allergy and clinical immunology.
[54] M. Mack,et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease , 2003, Nature Medicine.
[55] A. Mercenier,et al. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. , 2002, The Journal of allergy and clinical immunology.
[56] L. Cosmi,et al. Phenotype, Localization, and Mechanism of Suppression of CD4+CD25+ Human Thymocytes , 2002, The Journal of experimental medicine.
[57] M. Ernst,et al. Platelet Factor 4 Inhibits Proliferation and Cytokine Release of Activated Human T Cells1 , 2002, The Journal of Immunology.
[58] A. Gurney,et al. IL‐17: prototype member of an emerging cytokine family , 2002, Journal of leukocyte biology.
[59] L. Cosmi,et al. Reversal of human allergen-specific CRTH2+ T(H)2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide. , 2001, The Journal of allergy and clinical immunology.
[60] W. Strober,et al. Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β , 2001, The Journal of experimental medicine.
[61] J. Shellito,et al. Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.
[62] M. Roncarolo,et al. Type 1 T regulatory cells , 2001, Immunological reviews.
[63] H. Weiner,et al. Induction and mechanism of action of transforming growth factor‐β‐secreting Th3 regulatory cells , 2001, Immunological reviews.
[64] E Lazzeri,et al. Chemokines and lymphopoiesis in human thymus. , 2001, Trends in immunology.
[65] H. Smits,et al. IL‐12‐induced reversal of human Th2 cells is accompanied by full restoration of IL‐12 responsiveness and loss of GATA‐3 expression , 2001, European journal of immunology.
[66] H. Asnagli,et al. Stability and commitment in T helper cell development. , 2001, Current opinion in immunology.
[67] J. Egen,et al. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. , 2001, Annual review of immunology.
[68] H. Ochs,et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.
[69] D. Galas,et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.
[70] Fiona Powrie,et al. Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.
[71] E. Raz,et al. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. , 2000, The Journal of allergy and clinical immunology.
[72] S. Sakaguchi. Regulatory T cells , 2000, Cell.
[73] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[74] F. Annunziato,et al. Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors. , 1999, Journal of immunology.
[75] U. Andersson,et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. , 1999, Atherosclerosis.
[76] V. Gangur,et al. Human Ip-10 Selectively Promotes Dominance of Polyclonally Activated and Environmental Antigen- Driven Ifn-g over Il-4 Responses Human Ip-10 Selectively Promotes Dominance of Polyclonally Activated and Environmental Antigen- Driven Ifn-g over Il-4 Responses. Faseb , 2022 .
[77] J. Holloway,et al. Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway Eosinophilia , 1998, The Journal of experimental medicine.
[78] S. Romagnani,et al. The Th1/Th2 paradigm. , 1997, Immunology today.
[79] W. Karpus,et al. Differential CC chemokine-induced enhancement of T helper cell cytokine production. , 1997, Journal of immunology.
[80] S. Park,et al. Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.
[81] Kenneth M. Murphy,et al. Functional diversity of helper T lymphocytes , 1996, Nature.
[82] M. Wills-Karp,et al. Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. , 1996, Journal of immunology.
[83] E. Gelfand,et al. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. , 1996, Journal of immunology.
[84] G. Trinchieri,et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. , 1996, Journal of immunology.
[85] R. Pauwels,et al. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. , 1996, American journal of respiratory and critical care medicine.
[86] F. Annunziato,et al. Polyinosinic acid: polycytidylic acid promotes T helper type 1‐specific immune responses by stimulating macrophage production of interferon‐α and interleukin‐12 , 1995, European journal of immunology.
[87] S. Romagnani. Lymphokine production by human T cells in disease states. , 1994, Annual review of immunology.
[88] C. Hsieh,et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.
[89] G. Trinchieri,et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.
[90] M. de Carli,et al. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. , 1992, Journal of immunology.
[91] M. de Carli,et al. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. , 1992, Journal of immunology.
[92] S. Romagnani. Human TH1 and TH2 subsets: doubt no more. , 1991, Immunology today.
[93] A. Abbas,et al. Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution , 1990, Infection and immunity.
[94] W. Paul,et al. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells , 1990, The Journal of experimental medicine.
[95] R. Coffman,et al. Heterogeneity of cytokine secretion patterns and functions of helper T cells. , 1989, Advances in immunology.
[96] R. Coffman,et al. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.
[97] D. Green,et al. Immunoregulatory T-cell pathways. , 1983, Annual review of immunology.
[98] S. Liebhaber,et al. Suppressor T cells. , 1972, Journal of immunology.